About Mecuris
Mecuris is a company based in Munchen (Germany) founded in 2015 by Simon Weidert and Felix Gundlack. It operates as a B2B. Mecuris has raised $8.13 million across 3 funding rounds from investors including Vesalius Biocapital Partners, Sana Kliniken and Bayern Kapital. The company has 34 employees as of December 31, 2020. Mecuris operates in a competitive market with competitors including Restor3D, Unyq, Motorica, Open Bionics and Focus Motion, among others.
- Headquarter Munchen, Germany
- Employees 34 as on 31 Dec, 2020
- Founders Simon Weidert, Felix Gundlack
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mecuris Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.13 M (USD)
in 3 rounds
-
Latest Funding Round
$4 M (USD), Series A
Jan 13, 2020
-
Investors
Vesalius Biocapital Partners
& 5 more
-
Employee Count
34
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Mecuris
Mecuris has successfully raised a total of $8.13M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.0M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series A - Mecuris | Valuation | Bayern Kapital , HTGF |
|
| Jan, 2019 | Amount | Series A - Mecuris | Valuation | MULCAN , Vesalius Biocapital III | |
| Nov, 2016 | Amount | Seed - Mecuris | Valuation | Bayern Kapital , HTGF |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mecuris
Mecuris has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Vesalius Biocapital Partners, Sana Kliniken and Bayern Kapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
Life sciences-focused VC firm investing in Europe and Canada
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mecuris
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mecuris
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mecuris Comparisons
Competitors of Mecuris
Mecuris operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Restor3D, Unyq, Motorica, Open Bionics and Focus Motion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
3D printing technology is developed for human body reconstruction.
|
|
| domain | founded_year | HQ Location |
Custom 3D-printed prosthetic fairings and accessories are supplied to amputees.
|
|
| domain | founded_year | HQ Location |
3D-printed upper limb prosthetics are developed for injury restoration.
|
|
| domain | founded_year | HQ Location |
Robotic prosthetic hands are manufactured using 3D printing technology.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based wearables and application for health, wellness and fitness
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Mecuris
When was Mecuris founded?
Mecuris was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Mecuris located?
Mecuris is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Is Mecuris a funded company?
Mecuris is a funded company, having raised a total of $8.13M across 3 funding rounds to date.
How many employees does Mecuris have?
As of Dec 31, 2020, the latest employee count at Mecuris is 34.
What does Mecuris do?
Mecuris operates with a B2B model, focusing on providing healthcare solutions, medical technology, orthopedics, and design software. Offers digital CADCAM solutions for designing orthopedic implants. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Mecuris?
Who are Mecuris's investors?
Mecuris has 6 investors. Key investors include Vesalius Biocapital Partners, Sana Kliniken, Bayern Kapital, High-Tech Gründerfonds, and MULCAN.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.